Context:

• Three major health surveys were recently released in India — the National Family Health Survey (NFHS-6), the NSO 80th Round Household Consumption Survey on Health, and the National Health Accounts Estimates for India 2022-23.
• Together, they should have triggered serious national stocktaking. Instead, they generated headlines but little policy action — exposing a deep structural problem in how India uses its health data.
• This article highlights the disconnect between India's extensive health data collection and the limited policy action that follows.
• It argues that health surveys should serve as instruments of accountability and course correction rather than merely generating headlines, political claims, or commercial opportunities.

The Paradox of Health Surveys in India

• India's health surveys follow a predictable and unproductive cycle:
  • The government highlights achievements and celebrates positive indicators
  • Newspapers amplify numbers without sustained critical analysis
  • Academics wait for raw data, which arrives late
  • Industry identifies market opportunities from every health challenge flagged
• The result: surveys confirm what is already known, fail to spotlight what has stagnated, and rarely trigger immediate programmatic reform.
• A health survey is meant to be an instrument of course correction — not a ritual of self-congratulation.

What the Surveys Reveal: Old Problems, New Numbers

• The NFHS-6 data — collected in 2023-24 but released in mid-2026 — flags the rise of obesity, diabetes, hypertension, and other non-communicable diseases (NCDs) across all social and economic groups, not just urban and affluent populations.
• Anaemia remains persistent. Out-of-pocket health expenditure stays high. Child nutrition has stagnated in several areas.
• None of this is new. The surveys merely put fresh numbers to old warnings that were never adequately acted upon.

How Industry Exploits Health Data?

• Where public health messaging is weak, private markets are quick to fill the gap:
  • Rising obesity → weight-loss products, apps, gyms, diagnostic packages
  • Rising diabetes → monitoring devices, private clinics, test packages
  • Rising NCDs → medicalisation, screening drives, private sector expansion
• Survey data, instead of driving public health reform, ends up fuelling commercial health markets. This is a failure of governance, not of data.

The Temporal Problem: Convenient Lag

• The gap between data collection (2023-24) and public release (2026) creates a politically convenient loophole.
• Governments can claim credit for positive trends as proof of current policy success, while dismissing troubling findings as "old data" linked to COVID-19 disruptions or past administrative failures.
• Similarly, raw data are released late, meaning peer-reviewed academic analysis often takes three to five years after data collection.
• By then, policymakers dismiss the findings as outdated. Data lose their impact precisely when they are needed most.

From Data to Action: Five Reforms Needed

• Mandatory Action Notes within 30–45 Days
  • Every major health survey must be followed by a national and state-level action note — jointly prepared by government and independent institutions — candidly identifying what improved, what stagnated, and what deteriorated.
  • Each finding must be linked to a specific programme and a clearly accountable authority.
• State-Level Working Reviews — Not Ceremonial Events
  • Health Secretaries, Finance Departments, district officials, public health experts, and civil society must review findings together.
  • The core question should not be "what can we highlight?" but "what must we change?"
• Integrated Data Systems
  • Survey data, HMIS (Health Management Information System) data, and the Integrated Health Information Platform (IHIP) data must be combined for coherent analytical output. Fragmented data produce fragmented policy.
• Early Release of Raw Data as a Public Good
  • Primary source data must be made available promptly so independent researchers can produce rapid analysis.
  • Data should not be treated as a guarded file — they must function as a public good.
• Data Must Influence Budget Allocations
  • Survey findings must directly shape how money is spent. Rising NCDs must mean larger primary care budgets.
  • High out-of-pocket medicine costs must mean stronger public drug availability.
  • Data without budgetary consequence are merely information.

Conclusion

• India collects vast health data but harvests little accountability from it.
• A survey that triggers no programme change, no budget reallocation, and no official accountability is not a public health tool — it is a public relations exercise.
• The true measure of any health survey is not the headlines it generates, but the reforms it compels.